T1	Treatment 20 112	recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene
T2	Treatment 288 365	rAAV2-TNFR:Fc, an adenoassociated virus serotype 2 vector containing the cDNA
T3	Treatment 512 530	placebo-controlled
T4	Treatment 893 906	rAAV2-TNFR:Fc
T5	Treatment 997 1007	or placebo
